secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0000950170-24-066242
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Medical Group reiterates 2024 Adj. EBITDA guidance of $200M-$220M, portfolio optimization with $30M impact
--------------------------------------------------------------------------------

- Company exiting office-based practices and primary/urgent care by end of 2024.
- Annualized Adj. EBITDA impact of portfolio optimization ~$30M (based on 2023 results).
- Reiterates 2024 Adj. EBITDA guidance range of $200M to $220M, including in-year impact.
- Focus on operating efficiency and margin stabilization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017024066242/0000950170-24-066242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017024066242/md-20240530.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-066242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer